ERBB2 and cancer: Further enhancing the accuracy of the approach, the EFTUD2 locus is frequently subject to heterozygous loss in HER2 amplified cancers (Figure 1), which therefore enhances the HER2:EFTUD2 ratio in amplified cancers.